American Journal of Cardiology
Volume 104, Issue 10 , Pages 1317-1323 , 15 November 2009

Prognostic Impact of Types of Atrial Fibrillation in Acute Coronary Syndromes

  • Dennis H. Lau, MBBS

      Affiliations

    • Cardiovascular Research Centre, Department of Cardiology, Royal Adelaide Hospital and Disciplines of Medicine and Physiology, University of Adelaide, Adelaide, South Australia, Australia
    • ,
  • Luan T. Huynh, MBBS

      Affiliations

    • Department of Cardiology, Flinders Medical Centre and Department of Medicine, Flinders University, Adelaide, South Australia, Australia
    • ,
  • Derek P. Chew, MBBS, MPH

      Affiliations

    • Department of Cardiology, Flinders Medical Centre and Department of Medicine, Flinders University, Adelaide, South Australia, Australia
    • ,
  • Carolyn M. Astley, BN

      Affiliations

    • Department of Cardiology, Flinders Medical Centre and Department of Medicine, Flinders University, Adelaide, South Australia, Australia
    • ,
  • Ashish Soman, MBBS

      Affiliations

    • Sanofi-Aventis, Macquerie Park, New South Wales, Australia
    • ,
  • Prashanthan Sanders, MBBS, PhD

      Affiliations

    • Cardiovascular Research Centre, Department of Cardiology, Royal Adelaide Hospital and Disciplines of Medicine and Physiology, University of Adelaide, Adelaide, South Australia, Australia
    • Corresponding Author InformationCorresponding author: Tel: (+61) 8-8222-2723; fax: (+61) 8-8222-2722

Received 19 March 2009 ,Revised 19 June 2009 ,Accepted 19 June 2009.

References 

  1. Cristal N, Szwarcberg J, Gueron M. Supraventricular arrhythmias in acute myocardial infarction: prognostic importance of clinical setting; mechanism of production. Ann Intern Med. 1975;82:35–39
  2. Hunt D, Sloman G, Penington C. Effects of atrial fibrillation on prognosis of acute myocardial infarction. Br Heart J. 1978;40:303–307
  3. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era (SPRINT and thrombolytic survey groups). Circulation. 1998;97:965–970
  4. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C TRACE (TRAndolapril Cardiac Evaluation) study group. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. Eur Heart J. 1999;20:748–754
  5. Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86:527–532
  6. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969–974
  7. Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol. 1997;80:1522–1527
  8. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878–885
  9. Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am Heart J. 2002;143:519–527
  10. Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150–1154
  11. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031–1036
  12. Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008;94:867–873
  13. Chew DP, Amerena J, Coverdale S, Rankin J, Astley C, Brieger D. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Int Med J. 2007;37:741–748
  14. Chew DP, Allan RM, Aroney CN, Sheerin NJ. National data elements for the clinical management of acute coronary syndromes. Med J Aust. 2005;182:S1–S14
  15. Kochiadakis GE, Skalidis EI, Kalebubas MD, Igoumenidis NE, Chrysostomakis SI, Kanoupakis EM, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J. 2002;23:734–741
  16. White CW, Holida MD, Marcus ML. Effects of acute atrial fibrillation on the vasodilator reserve of the canine atrium. Cardiovasc Res. 1986;20:683–689
  17. Wichmann J, Ertl G, Rudolph G, Kochsiek K. Effect of experimentally induced atrial fibrillation on coronary circulation in dogs. Basic Res Cardiol. 1983;78:473–491
  18. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107:1930–1936
  19. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation. 2003;108:1461–1468
  20. Shimizu A, Nozaki A, Rudy Y, Waldo AL. Onset of induced atrial flutter in the canine pericarditis model. J Am Coll Cardiol. 1991;17:1223–1234
  21. Rechavia E, Strasberg B, Mager A, Zafrir N, Kusniec J, Sagie A, et al. The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement. Am Heart J. 1992;124:387–391
  22. Sugiura T, Iwasaka T, Takahashi N, Yuasa F, Takeuchi M, Hasegawa T, et al. Factors associated with atrial fibrillation in Q wave anterior myocardial infarction. Am Heart J. 1991;121:1409–1412
  23. Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK, et al. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J. 1989;117:86–92
  24. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96:1686–1695
  25. Olgin JE, Sih HJ, Hanish S, Jayachandran JV, Wu J, Zheng QH, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998;98:2608–2614
  26. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:833–842
  27. Stenestrand U, Lindback J, Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation. 2005;112:3225–3231

 This data collection for the ACACIA cohort was sponsored by Sanofi-Aventis, Australia Pty, Ltd., Macquerie Park, New South Wales, Australia. Dr. Lau was supported by a medical postgraduate scholarship from the National Health and Medical Research Council of Australia, Canberra, Australian Capital Territory, Australia; the Bakken Electrophysiology Scholarship from the University of Adelaide, Adelaide, South Australia, Australia; and a biomedical research scholarship from Kidney Health Australia, Melbourne, Victoria, Australia. Drs. Chew and Sanders were supported by the National Heart Foundation of Australia, Adelaide, South Australia, Australia.

PII: S0002-9149(09)01317-4

doi: 10.1016/j.amjcard.2009.06.055

American Journal of Cardiology
Volume 104, Issue 10 , Pages 1317-1323 , 15 November 2009

Article Tools

* Image Usage & Resolution